Gland Pharma Ltd.
| BSE: 543245 | Sector: Health care |
| NSE: GLAND | ISIN Code: INE068V01023 |
| BSE 00:00 | 25 Jan | 3394.95 |
89.95 (2.72%) |
OPEN
3300.00 |
HIGH
3427.80 |
LOW
3267.40 |
| NSE 00:00 | 25 Jan | 3397.10 |
93.10 (2.82%) |
OPEN
3304.00 |
HIGH
3429.95 |
LOW
3270.00 |
| OPEN | 3300.00 |
| PREVIOUS CLOSE | 3305.00 |
| VOLUME | 8769 |
| 52-Week high | 4350.00 |
| 52-Week low | 2051.00 |
| P/E | 47.01 |
| Mkt Cap.(Rs cr) | 55,779 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
About Gland Pharma Ltd.
Gland Pharma Ltd
Gland Pharma Ltd was incorporated as Gland Pharma Private Limited' a private limited company under the Companies Act 1956 on March 20 1978 and was granted the certificate of incorporation by Registrar of Companies Andhra Pradesh at Hyderabad. Subsequently the name of the Company was changed to Gland Pharma Limited' pursuant to a special resolution passed by the shareholders of the Company on Decem...> More
Gland Pharma Ltd - Key Fundamentals
| Parameter | Values | ||
| Market Cap | ( cr) |
55,779 | |
| EPS - TTM | () |
[*S] | 72.22 |
| P/E Ratio | (X) | [*S] | 47.01 |
| Face Value | () |
1 | |
| Latest Dividend | (%) | - | |
| Latest Dividend Date | - | ||
| Dividend Yield | (%) | 0.00 | |
| Book Value / Share | () |
[*S] | 401.44 |
| P/B Ratio | () |
[*S] | 8.46 |
News
Gland Pharma Ltd - Financial Results
Particulars ( cr) |
Dec 2021 | Dec 2020 | % Chg |
| Net Sales | 1063.33 | 859.42 | 23.73 |
| Other Income | 45.67 | 35.13 | 30 |
| Total Income | 1108.99 | 894.55 | 23.97 |
| Total Expenses | 714.41 | 595.19 | 20.03 |
| Operating Profit | 394.58 | 299.36 | 31.81 |
| Net Profit | 273.03 | 204.11 | 33.77 |
| Equity Capital | 16.43 | 16.33 | - |
Gland Pharma Ltd - Peer Group
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| Dr Reddy's Labs | 4407.00 | 1.02 | 73341.29 |
| Cipla | 904.10 | 1.39 | 72942.79 |
| Piramal Enterp. | 2358.25 | -0.31 | 56279.64 |
| Gland Pharma | 3394.95 | 2.72 | 55779.03 |
| Torrent Pharma. | 3160.55 | 1.79 | 53482.83 |
| Biocon | 373.40 | 0.23 | 44830.40 |
| Lupin | 915.40 | -0.68 | 41577.47 |
Gland Pharma Ltd - SHAREHOLDING PATTERN
|
|
|
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
OtherGland Pharma Ltd - Research Reports
| Date | Broker | Action | Price | Report |
| 01/12/2021 | Emkay Global | Buy | 3608 |  Details |
| 22/07/2021 | Motilal Oswal | Buy | 3802 | Details |
| 18/05/2021 | Motilal Oswal | Buy | 2800 | Details |
Gland Pharma Ltd - RETURNS
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | -7.68% | -7.57% | -4.77% | -4.61% |
| 1 Month | -12.79% | -12.76% | 1.28% | 1.61% |
| 3 Month | -8.82% | -8.84% | -5.10% | -4.68% |
| 6 Month | -15.47% | -15.43% | 9.22% | 8.97% |
| 1 Year | 50.93% | 50.92% | 19.67% | 21.34% |
| 3 Year | NA | NA | 60.60% | 60.27% |
Gland Pharma Ltd - STOCK STRENGTH
| Today's Low/High | 3267.40 |
|
3427.80 |
| Week Low/High | 3250.00 |
|
3716.00 |
| Month Low/High | 3250.00 |
|
4060.00 |
| YEAR Low/High | 2051.00 |
|
4350.00 |
| All TIME Low/High | 1701.00 |
|
4350.00 |
Quick Links for Gland Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
